Onishi et al.14 also found that the early evaluation and treatment of cancer-related cardiac dysfunction improves patients’ quality of life, as early intervention lowers neprilysin, inhibits natriuretic peptide degradation, reduces aldosterone levels and blood pressure, promotes diuresis and vasodilation, and prevents myocardial remodeling. This evidence concerns the gene MME and cancer.